Olodaterol Bridging Study in Asthma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Relative Bioavailability of Bromhexine Given as Granules and Syrup in Healthy Volunteers (Clinical Phase I Study)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Adults With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Adults With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of BI 836845 for Various Solid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)
- Status
- COMPLETED
- Phase
- PHASE3
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)
- Status
- TERMINATED
- Phase
- PHASE2
Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
- Status
- TERMINATED
- Phase
- PHASE2
Drug Interaction Study With Rifampicin and Afatinib
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration
- Status
- COMPLETED
- Phase
- PHASE2
ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet
- Status
- COMPLETED
- Phase
- PHASE1